These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 22018894)

  • 21. [Relevance of plasma exchange in the treatment of myasthenia gravis: study of 11 cases].
    Miladi MI; Feki I; Kammoun H; Elleuch H; Triki C; Gargouri J; Mhiri C
    Rev Med Interne; 2008 Feb; 29(2):87-93. PubMed ID: 18035453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma exchange in the treatment of myasthenia gravis].
    Nishitani H; Konishi T; Ota M; Matsubara F; Ohi T; Motomura S
    Nihon Rinsho; 1981 Oct; 39(10):3302-9. PubMed ID: 7339020
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical study of double filtration plasmapheresis for treatment of refractory myasthenia gravis].
    Huo JT; Long HL; Luo X; Xu JZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):355-7. PubMed ID: 17425991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravis.
    Blaha M; Pit'ha J; Blaha V; Lanska M; Maly J; Filip S; Langrova H
    J Biomed Biotechnol; 2010; 2010():419520. PubMed ID: 20300435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of immunoadsorption therapy in the treatment of myasthenia gravis and the mechanism].
    LI QL; XIE FH; LUO YS
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):561-3. PubMed ID: 21421508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmapheresis].
    Tesar V; Jelínková E; Jirsa M; Bakosová N; Pit'ha V; Chábová V
    Cas Lek Cesk; 1998 Nov; 137(21):654-9. PubMed ID: 9929930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Successful perioperative management with plasma exchange for elderly patient with myasthenia gravis; report of a case].
    Takeshige M; Aoki T; Motono N; Shimada K; Nakayama T; Yazawa M
    Kyobu Geka; 2009 Nov; 62(12):1105-7. PubMed ID: 19894581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of myasthenia gravis].
    Rilling G; Tettenborn B
    Praxis (Bern 1994); 2001 Aug; 90(33):1350-4. PubMed ID: 11534319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of plasmapheresis in myasthenia gravis: delayed therapy is not favorable.
    Mandawat A; Mandawat A; Kaminski HJ; Shaker ZA; Alawi AA; Alshekhlee A
    Muscle Nerve; 2011 Apr; 43(4):578-84. PubMed ID: 21404289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of plasma exchange on carbamazepine levels in a patient with myasthenia gravis and epilepsy.
    Siddiqi ZA; Holt A; Ahmed SN
    Epilepsia; 2005 Nov; 46(11):1841-2. PubMed ID: 16302866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma exchange combined with immunosuppressive therapy in myasthenia gravis].
    Tanaka M; Nagai H; Mori S; Miyatake T; Shinada S
    No To Shinkei; 1982 Jul; 34(7):699-703. PubMed ID: 7138697
    [No Abstract]   [Full Text] [Related]  

  • 34. [Care of myasthenia gravis patients treated by blood plasma exchange].
    Gui XS; Ye YY
    Zhonghua Hu Li Za Zhi; 1988 Jan; 23(1):7-9. PubMed ID: 3383297
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of plasma exchange in treatment of myasthenia gravis.
    Dau PC
    Prog Clin Biol Res; 1982; 106():143-56. PubMed ID: 7178136
    [No Abstract]   [Full Text] [Related]  

  • 36. The six year experience of plasmapheresis in patients with myasthenia gravis.
    Chiu HC; Chen WH; Yeh JH
    Ther Apher; 2000 Aug; 4(4):291-5. PubMed ID: 10975476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of prethymectomy plasma exchange on postoperative respiratory function in myasthenia gravis.
    d'Empaire G; Hoaglin DC; Perlo VP; Pontoppidan H
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):592-6. PubMed ID: 3982061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experience in the treatment of acute fulminating myasthenia gravis].
    Ouchi M; Shoji Y; Yoshida I; Itoh Y; Ohmi M; Saji K
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Feb; 40(2):265-72. PubMed ID: 1593167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma exchange in myasthenia gravis: electrophysiological studies.
    Campbell WW; Leshner RT; Swift TR
    Ann Neurol; 1980 Dec; 8(6):584-9. PubMed ID: 6260011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.